Verdezyne Raises $6.3M
Bruce V. Bigelow12/2/10
Carlsbad, CA-based Verdezyne, which is developing gene libraries for use in industrial biology, has raised $6.3 million of a targeted $15 million equity round, according to a recent regulatory filing. The company, which secured $9 million toward a $15 million round in February, declined to comment, so it’s unclear whether the latest funding represents additional money or a follow-on tranche of the previous round. Verdezyne has initially focused on developing renewable technologies for making adipic acid, a key feedstock chemical used to make nylon. The company’s investors include Monitor Ventures, OVP Venture Partners, the Tech Coast Angels, and the Life Sciences Angels. A representative of BP Alternative Energy Ltd. also is on its board.
